A New Formula For Consumer Advocacy

April 25, 2012
Our team at OPEN MINDS has extensive coverage of the many new treatment technologies available for brain disorders (just in the past few months, we've covered Smartphone App Monitors & Predicts Depression Triggers, Improves Depression Levels and Text Messaging Program Improved Medication Adherence For Consumers With Schizophrenia ).

But, as exciting as these developments are, our science-to-service lag is discouraging – 17 years on average from scientific validation to widespread adoption in the service delivery system. Why do we have such lousy coordination of science, policy and practice in the health and human service field? And . . .